Cargando…
Esophagus-duodenum Gastric Bypass Surgery Improves Glucose and Lipid Metabolism in Mice
BACKGROUND: Despite of its significant therapeutic effects on obesity and metabolic diseases, Roux-en-Y gastric bypass (RYGB) has limited clinical application because of considerable impacts on the gastrointestinal structure and postoperative complications. This study aims to develop a simplified su...
Autores principales: | He, Rui, Yin, Yue, Li, Yin, Li, Ziru, Zhao, Jing, Zhang, Weizhen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5898028/ https://www.ncbi.nlm.nih.gov/pubmed/29398599 http://dx.doi.org/10.1016/j.ebiom.2018.01.032 |
Ejemplares similares
-
Prevention of pancreatic acinar cell carcinoma by Roux-en-Y Gastric Bypass Surgery
por: He, Rui, et al.
Publicado: (2018) -
Activation of mTORC1 signaling in gastric X/A-like cells induces spontaneous pancreatic fibrosis and derangement of glucose metabolism by reducing ghrelin production
por: Yu, Ruili, et al.
Publicado: (2018) -
Crohn’s disease of esophagus, stomach and duodenum
por: Pimentel, Andréa Maia, et al.
Publicado: (2019) -
Potential Mechanisms of Gut-Derived Extracellular Vesicle Participation in Glucose and Lipid Homeostasis
por: Feng, Tiange, et al.
Publicado: (2022) -
Peripheral Effects of Nesfatin-1 on Glucose Homeostasis
por: Li, Ziru, et al.
Publicado: (2013)